Severity
Moderate
FDA Devices recall · Reported February 18, 2026
Presence of particulates in affected devices that can be deposited into breast tissue during use.
Hologic, Inc recalled Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument. - a moderate-severity action.
Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument. was recalled by Hologic, Inc in February 18, 2026. Reason: Presence of particulates in affected devices that can be deposited into breast tissue during use.. Check the official notice for the remedy. Verify recall #Z-1314-2026 with the FDA Devices before acting.
The recall
Hologic, Inc issued this moderate-severity FDA Devices recall-Presence of particulates in affected devices that can be deposited into breast tissue during use..
Sourced from official FDA Devices enforcement records. Verify recall #Z-1314-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1314-2026) was formally reported on February 18, 2026, with the manufacturer initiating the action on December 15, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. Hologic, Inc is listed as the recalling firm, operating out of Marlborough, MA. Federal records list the affected scope as 681,870 units, a scale large enough to require multi-state distribution tracking.
The documented reason for this recall is: Presence of particulates in affected devices that can be deposited into breast tissue during use. Distribution data in the federal record shows the product reached: US Nationwide distribution.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
681,870 units
Related Recalls
6
3 from same agency
Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.
Presence of particulates in affected devices that can be deposited into breast tissue during use.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | Z-1314-2026 |
| Date reported | February 18, 2026 |
| Date initiated | December 15, 2025 |
| Recalling firm | Hologic, Inc |
| Firm location | Marlborough, MA |
| Affected scope | 681,870 units |
| Distribution | US Nationwide distribution. |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported February 18, 2026. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.